Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $165,520 - $194,586
2,674 Added 15.7%
19,702 $1.32 Million
Q2 2023

Aug 15, 2023

BUY
$53.34 - $63.11 $214,320 - $253,575
4,018 Added 30.88%
17,028 $1.07 Million
Q1 2023

May 15, 2023

BUY
$51.63 - $56.93 $671,706 - $740,659
13,010 New
13,010 $740,000
Q4 2020

Feb 08, 2021

SELL
$62.61 - $71.29 $632,924 - $720,670
-10,109 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$39.55 - $54.65 $17,441 - $24,100
-441 Reduced 4.18%
10,109 $536,000
Q4 2019

Feb 18, 2020

SELL
$36.66 - $41.78 $13,197 - $15,040
-360 Reduced 3.3%
10,550 $428,000
Q3 2019

Nov 14, 2019

SELL
$34.82 - $39.26 $9,053 - $10,207
-260 Reduced 2.33%
10,910 $413,000
Q2 2019

Aug 14, 2019

BUY
$36.05 - $42.76 $67,305 - $79,832
1,867 Added 20.07%
11,170 $419,000
Q3 2018

Nov 08, 2018

SELL
$29.25 - $36.73 $289,955 - $364,104
-9,913 Reduced 51.59%
9,303 $322,000
Q1 2018

May 14, 2018

SELL
$31.93 - $39.54 $22,351 - $27,678
-700 Reduced 3.51%
19,216 $628,000
Q4 2017

Feb 13, 2018

SELL
$34.15 - $37.62 $5,805 - $6,395
-170 Reduced 0.85%
19,916 $748,000
Q3 2017

Nov 13, 2017

BUY
$30.11 - $37.72 $604,789 - $757,643
20,086
20,086 $717,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.